Research in Drug Development (RD3)

Pharmacognosy Bioanalysis and Drug Discovery

Contact
 

Research activities

His research field is the analysis of posttranslational modifications (PTMs) of proteins by mass spectrometry. The targeted PTMs are the oxidative ones (oxidation of tryptophan, tyrosine, lysine, cysteine, …) in the context of chronic inflammation pathologies/oxidative stress like in atherosclerosis/cardiovascular disease. Another type of PTMs that he studies, is the glycosylation. Glycosylation is the most abundant modification of proteins, and in the context of therapeutic proteins, more than 60 % of the currently approved biotherapeutics are glycosylated. His research is also devoted to the development of analytical tools for the other “omics” fields mainly metabolomics and proteomics. He currently develops his research projects in the RD3-PBM unit and the Analytical Platform of the Faculty of Pharmacy

Top ten recent articles

En attente des données.
Rafraîchir.